BBOT Competitors & Alternatives
Compare BridgeBio Oncology Therapeutics, Inc. with similar stocks in the same industry
Biotechnology
BBOT
Main Stock$8.11
Tradestie Score
64
Market Cap
$952.74M
Analyst Upside
+209.6%
Top Competitors
232 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
PVLA
Palvella Therapeutics, Inc. Common Stock
|
$146.76
|
$699.30M | - | 59 | Compare |
|
GYRE
Gyre Therapeutics, Inc. Common Stock
|
$7.34
|
$688.47M | - | 57 | Compare |
|
TERN
Terns Pharmaceuticals, Inc. Common Stock
|
$52.95
|
$683.46M | - | 57 | Compare |
|
ANL
ANL
|
$9.49
|
$682.62M | - | 58 | Compare |
|
ARVN
Arvinas, Inc
|
$8.39
|
$670.30M | - | 51 | Compare |
|
MGTX
MeiraGTx Holdings plc Ordinary Shares
|
$13.92
|
$665.30M | - | 59 | Compare |
|
ERAS
Erasca, Inc. Common Stock
|
$18.47
|
$626.91M | - | 60 | Compare |
|
SVRA
Savara Inc.
|
$6.22
|
$611.84M | - | 64 | Compare |
|
KALV
KalVista Pharmaceuticals, Inc. Common Stock
|
$27.00
|
$608.81M | - | 57 | Compare |
|
CTMX
CytomX Therapeutics, Inc.
|
$3.82
|
$552.46M | - | 58 | Compare |
More BBOT Analysis
Data updated: Jul 05, 2026 | Industry: Biotechnology (SIC 2834)
232 stocks in this industry